In 2015, risk-based monitoring (RBM) was making waves. That year Industry Standard Research (ISR) published an infographic which stated, “Increasingly sophisticated EDC capabilities, declining R&D productivity, and new regulatory guidance combined to create the ideal time to implement Risk-Based Monitoring.” Not everyone was happy with the trend. Many felt many CRAs would be displaced, as RBM would inevitably result in sponsors and CROs requiring fewer of them. Articles appearing on multiple media sources in 2016 all warned that the future looked challenging for CRAs. One blog advised CRAs to enjoy their superstar status because the number of jobs available to them could be cut in half over the next 10 years. It now seems some of those projections may have missed the mark.Read more at Clinical Leader, and learn about our report CRA Salary Analysis and Work Environment.
Editor Ed Miseta at Clinical Leader discusses CRA compensation and the CRA/RBM relationship.